Back in a jiffy!
Currently in clinical microbiology, the gold standard process utilizes cell culturing followed by immunoassay or nucleic-acid based analysis. This diagnostic cycle takes several days to a week, and often leads to unnecessary patient suffering, disease spreading, and antibiotic drug usage. There is a strong and growing demand for rapid point-of care molecular diagnostic procedures. Our technology, AnyMDx, aims to address this critical need. AnyMDx is a mobile nucleic acid diagnostic platform that can be used for anyone anywhere, anytime. AnyMDx consists of a compact analyzer, a disposable disease-specific reagent cartridge, and an optional smartphone app for result interpretation. By leveraging advanced microfluidic, microelectronic and optic technologies, AnyMDx is the first genetic analyzer to integrate all the required steps in nucleic acid diagnosis, including sample preparation, amplification and results reading, in a ‘sample-in-answer-out’ fashion. AnyMDx can handle a wide variety of samples: whole blood, saliva, swab, sputum, urine, stool, and various pathogen types: parasites, bacteria, viruses. It requires no expertise to run the advanced molecular diagnosis and delivers results in under 40 minutes. Our technology reduces the cost/time for molecular diagnostics by at least a factor of 10. AnyMDx provides an invaluable accurate early diagnosis in a sensitive and economic way.
Nov 02 2016Organization
Contact this team about Funding, Collaboration or other methods of support. Contact Team